Background: Although surgical field visualization is important in functional endoscopic sinus surgery (FESS), the complications associated with controlled hypotension for surgery should be considered. Intraoperative hypotension is associated with postoperative stroke, leading to subsequent hypoxia with potential neurologic injury. We investigated the effect of propofol and desflurane anesthesia on S-100b and glial fibrillary acidic protein (GFAP) levels which are early biomarkers for cerebral ischemic change during controlled hypotension for FESS.
Introduction
Functional endoscopic sinus surgery (FESS) is an effective lowrisk procedure and is performed commonly for chronic sinusitis. However, bleeding into the small surgical field can lead to serious complications. Providing optimal visualization of the surgical field is essential for adequate surgical exposure and for identification of crucial neurovascular structures. [1] Controlled hypotension is one of the techniques used for minimizing bleeding during FESS. [2] [3] [4] Controlled hypotension can be achieved by using various anesthetic agents, but there is no consensus on which agent is superior. However, a combination of propofol and remifentanil infusion produces controlled hypotension without the need for additional hypotensive agents; further, it provides better surgical field visualization with less bleeding compared with traditional inhalational anesthetic techniques and is currently the preferred technique for FESS. [1, 2, 5] Although surgical field visualization is important, the complications associated with controlled hypotension should also be considered. Extreme hypotension may cause cognitive dysfunction, organ hypoperfusion, and subsequent ischemic injury. [2, [6] [7] [8] [9] [10] S-100b and glial fibrillary acidic protein (GFAP) are early biomarkers for blood-brain barrier (BBB) damage and cerebral ischemic change. [11] [12] [13] [14] Further, the effect of propofol/ remifentanil anesthesia for controlled hypotension on cerebral ischemia, apart from its effect on improving surgical field visualization, needs to be evaluated. In this study, we investigated the effect of propofol/remifentanil and desflurane/remifentanil anesthesia on S-100b and GFAP levels during controlled hypotension for FESS.
Methods

Study design and patient selection
This prospective study protocol was approved by the Institutional Review Board of Chuncheon Sacred Heart Hospital, Chuncheon, South Korea (no: 2017-74) and was registered on the Clinical Information Service (available at: http://cris.nih.go.kr, KCT 0002698). Patients with a diagnosis of rhinosinusitis (defined as the presence of sinus symptoms persisting for at least 3 months despite medical therapy), aged over 20 years, and undergoing FESS were enrolled; written informed consent was obtained from all patients. Exclusion criteria included uncontrolled hypertension, diabetes, renal disease, history of cerebrovascular disease, and dementia. The included patients were divided into a propofol group and a desflurane group. The patients were randomly allocated to the groups using a computer-generated, permutedblock schedule (block size = 4) by an independent nurse who prepared the anesthesia agent according to the assignment.
Anesthesia and controlled hypotension
No premedication was given. On arriving in the operating room, standard monitoring was performed using electrocardiography, pulse oximeter, noninvasive blood pressure monitoring, and bispectral index (BIS). Anesthesia was induced with propofol (target concentration 3-5 ng/mL), remifentanil (0-0.2 mg/kg/min), and rocuronium (0.8 mg/kg) in propofol group and with propofol (2 mg/kg), remifentanil (0-0.2 mg/kg/min), and rocuronium (0.8 mg/kg) in desflurane group. After endotracheal intubation, ventilation was controlled mechanically with a mixture of 50% oxygen in N 2 O to maintain the end tidal carbon dioxide (EtCO 2 ) at 35 to 40 mm Hg. Anesthesia was maintained with propofol and remifentanil (0-0.4 mg/kg/min) in propofol group and with desflurane and remifentanil (0-0.4 mg/kg/min) in desflurane group. The dose of each agent was adjusted to maintain the mean arterial blood pressure (MAP) at 60 to 70 mm Hg and the BIS at 40 to 60. Propofol, desflurane and remifentanil served mainly to control the target MAP, and nicardipine and phenylephrine were also used as needed. Patients were excluded if the target MAP could not be maintained within 5 minutes. A radial arterial catheter was inserted for continuous blood pressure monitoring and for taking a blood sample for measuring the levels of S-100b and GFAP. The pressure transducer used for radial artery pressure measurement was zeroed at the level of the external auditory meatus throughout the surgery. After anesthesia induction and establishment of an arterial line, the patient was positioned in a reverse Trendelenburg position at 15°. Arterial blood gas analysis (ABGA) was performed 20 and 60 minutes after the patient was placed in the reverse Trendelenburg position and controlled hypotension were achieved. Surgery in all patients was performed by a single experienced surgeon.
After completion of the surgery, the patient was repositioned to be supine; then, anesthesia was discontinued and the neuromuscular block was reversed. After adequate awakening, the patient was extubated and transported to the recovery room, where the MAP was monitored continuously to check for hypotension (20% of the preoperative value).
S-100b and GFAP measurement
For S-100b and GFAP assay, an arterial blood sample was taken after arterial line catheterization (baseline), at 20 (T 20 ) and 60 (T 60 ) minutes after placing the patient in the reverse Trendelenburg position and achieving the target range of MAP, and at 60 minutes after surgery (Post 60 ). If the surgery was completed before T 60, T 60 was determined by the time at completion. The samples were centrifuged at 3000 rpm for 10 minutes, and serum was frozen within 30 minutes at À70°C until the end of this study. Serum S-100b was measured using a commercially available Human S100B (S100 calcium binding protein B) ELISA kit (MBS2503148; MyBioSource, San Diego, CA). The sensitivity of the assay is 18.75 pg/mL and detection range is 31.25 to 2000 pg/mL. The GFAP assay was performed using the Human GFAP ELISA kit (MBS2506721; MyBio-Source), which has a sensitivity of 0.188 ng/mL and detection range of 0.313 to 20 ng/mL.
PaCO 2 and EtCO 2
The ABGA was performed 20 and 60 minutes after placing the patient in the reverse Trendelenburg position and achieving the target range of MAP for comparison of PaCO 2 . EtCO 2 was also recorded at the same time.
Statistical analysis
The sample size of this study was calculated using G-power (ver. 3.1, a = 0.05, power = 0.8) for determination of a difference in S-100b levels between the 2 groups at 60 minutes after the surgery, depending on our preliminary study results (propofol group; mean = 265.89, standard deviation [SD] = 70.67, desflurane group; mean = 218.43, SD = 55.54, effect size = 0.75); a total of 30 patients were required in each group. Considering a 10% dropout rate, 34 patients per group were recruited. SPSS ver. 24.0 (SPSS Inc, Chicago, IL) was used for statistical analyses. Data are expressed as numbers or mean ± SD. The Student t test was used for comparisons of age, height, weight, body mass index (BMI), duration of controlled hypotension, anesthesia, and surgery. The levels of S-100b, GFAP, PaCO 2 , and EtCO 2 at each time-point were also compared between the 2 groups using Student t test. The changes in S-100b and GFAP levels within a group were compared using paired t test. The categorical data were analyzed using a Chi-squared test. A P-value <.05 was considered significant.
Results
A total of 68 patients undergoing FESS were allocated to the propofol and desflurane groups. Two patients in each group were excluded due to failure to maintain the target MAP during operation. In addition, 2 patients in the propofol group were excluded later owing to hemolysis of the blood samples; in the desflurane group, 1 patient was excluded owing to change in the surgical plan and 1 patient was excluded owing to hemolysis of the blood sample ( Fig. 1 ). In the recovery room, there was no case of hypotension. Table 1 shows the demographic data of each group. 
Levels of S-100b
The base levels of S-100b were 98.04 ± 78.57 and 112.61 ± 66.38 pg/mL in the propofol and desflurane groups, respectively. The S-100b levels were significantly increased in the intraoperative and postoperative periods compared to the baseline levels in both groups (P .001) ( Fig. 2 ). There was no significant difference at each time point between the 2 groups.
Levels of GFAP
The base levels of GFAP were 0.997 ± 0.486 and 0.898 ± 0.472 ng/mL in the propofol and desflurane groups, respectively. The GFAP levels were significantly increased in the intraoperative and postoperative periods compared to the baseline levels in both groups (P .001) ( Fig. 3 ). There was no significant difference at each time point between the 2 groups.
PaCO 2 and EtCO 2
The There was no significant difference between the 2 groups for these parameters ( Table 2 ).
Discussion
In this study, we evaluated the levels of S-100b and GFAP during controlled hypotension for FESS, which were observed to be raised in both the propofol and the desflurane groups. However, there were no significant differences between the groups regarding the measured parameters. Controlled hypotensive anesthesia can be defined as the reduction of MAP to 50 to 70 mm Hg, with the primary aim to improve surgical visibility without compromising perfusion to vital organs. [2] Although many agents can be used for controlled hypotension, total intravenous anesthesia (TIVA) with propofol and remifentanil is the preferred anesthetic technique. [1, 2, 5] In contrast to inhalational anesthetics, propofol infusion causes decreased perfusion pressure to the nasal cavity via the anterior and posterior ethmoid arteries by decreasing cerebral perfusion. Higher doses of inhalational anesthetics may cause additional vasodilation in the surgical field, increasing the likelihood of a worse visual field score. [4] On comparing propofol and sevoflurane anesthesia for FESS, propofol/remifentanil anesthesia was observed to be associated with less blood loss and provide better surgical conditions. [15] However, combined with remifentanil, inhalational anesthetics can induce adequate controlled hypotension and provide effective surgical conditions and favorable hemodynamics. [16] Therefore, it is difficult to determine which agent is better.
When controlled hypotension is induced, the associated complications as well as the importance of an optimal surgical field should be considered. [2, 9] Serious complications owing to organ hypoperfusion are uncommon, but intraoperative hypotension is associated with postoperative stroke, leading to subsequent hypoxia with potential neurologic injury. [7, 8, 17, 18] The mechanism of postoperative cerebral ischemia is multifactorial, and intraoperative hypotension may play a role in the occurrence of postoperative stroke by compromising blood flow to a potentially ischemic brain area. [18, 19] Postoperative cognitive dysfunction is also considered when performing controlled hypotension; cognitive dysfunction is also associated with brain cellular injury. [20] Intraoperative cerebral desaturation is known to be associated with a worse early cognitive outcome after onpump cardiac surgery. [21] One study reported that even when SpO 2 was in the normal range, cerebral desaturation was observed in 10% of the patients during controlled hypotension for rhinoplasty, and all patients with intraoperative cerebral desaturation showed decline in cognitive function after surgery. Therefore, the authors recommended monitoring cerebral oxygen saturation during controlled hypoperfusion. [22] The S-100b is an early marker of BBB damage, and a large elevation in its level indicates prior brain damage. [23] Serum S-100b values in healthy individuals range from 0.02 to 0.15 mg/L, as determined by immunoluminometric analytical methods. [24] Low (<0.34 ng/mL) serum levels are consistent with BBB opening without central nervous system damage. [23] GFAP is also a brainspecific biomarker, and increased plasma GFAP concentrations are associated with decline in cognition after noncardiac surgery. [20] The reported upper limit of GFAP in healthy subject was measured at <0.3 mg/L. [14, 25, 26] The normal range of each biomarkers may vary depending on which analytic test is used as in the research of Wunderlich et al [11] in which a new and 1st commercially available test kit was used and the GFAP levels differed from those of previous other studies. The ELISA kit used in this study has a sensitivity of 0.188 ng/mL and detection range of 0.313 to 20 ng/mL. Hence, we think that it is meaningful to compare the levels between the 2 groups and follow the levels and to predict the prognosis.
In stroke patients, S-100b and GFAP release were significantly correlated and may be considered predictors of the early disease course and functional outcome. [11, 14] The rapid release within 3 to 6 hours after stroke onset and a continuous increase with maximal GFAP concentration 48 hours after stroke may be caused by continued subsequent cell death or persistent disturbance of the BBB; S-100b can be elevated to 0.1 ng/mL as a result of BBB damage following and prior to neuronal damage. [11] [12] [13] Early increase in S-100b after surgery is associated with a cognitive dysfunction after surgery. [27] Hence, evaluation of GFAP and S-100b levels may be a useful approach for monitoring and evaluating the response to neuroprotective drugs. [14] Many recent studies have found that anesthetic agents may be neuroprotective and may provide cerebral protection in surgical patients. [28] In cardiac surgery, the effects of propofol and inhalational anesthetics on cerebral protection remain unclear. However, propofol is considered an ideal anesthetic for neurosurgery because of its presumed beneficial effects on cerebral physiology including reduction of cerebral metabolic rate and cerebral blood flow as well as brain relaxation. [29] One study reported that a sevoflurane-based volatile anesthesia regimen might be associated with better cognitive function compared with a propofol-based anesthesia regimen. [21] However, cerebral dysfunction and subtle cognitive changes after surgery are not readily detected in routine clinical examinations. [30] Evaluation of the level of a neurobiomarker such as S-100b and GFAP may be helpful to diagnose and prospect of the patients' neurocognitive function. A meta-analysis showed that S-100b levels assessed at the end of cardiopulmonary bypass and 24 hours postoperatively in cases of cardiac surgery, in which serious postoperative neuropsychologic complications were observed, were significantly lower in the inhalational anesthesia group than those in the TIVA group. [31] The increase in GFAP was also reduced in the volatile anesthetics group compared with the midazolam-fentanyl infusion group after cardiac surgery. [32] In this study, the increases in S-100b and GFAP levels were not different between the propofol and desflurane groups.
Although extreme hypotension causes serious complications, some research reported that lowering the MAP to 2/3 of the initial value did not cause any damage [33] and the degree of controlled intraoperative hypotension during FESS did not affect cognitive function after surgery. [3] However, there are many case reports of serious cerebral ischemia after controlled hypotension. In this study, we controlled the MAP at 60 to 70 mm Hg, and there were no clinical neurogenic complications after surgery. Common predisposing factors for perioperative stroke in noncardiac surgery are age, a previous stroke, atrial fibrillation, obesity, and vascular and metabolic diseases. [8, 17] However, high-risk patients with cerebral ischemia were excluded in this study; hence, when choosing the anesthetic technique for controlled hypotension, it would be useful to consider the results of previous studies for surgical field visualization along with the results of the present study on the potential concerns of cerebral ischemia. The anesthesiologist and surgeon should keep in mind that marked hypotension (MAP < 60 mm Hg) is associated with a potential risk of ischemic injury to the cerebrum. [2] We have some limitations in this study. First, the sample size was small though it was statistically significant. Second, the surgical field condition and amount of blood loss were not compared between the study groups. It have been reported that controlled hypotension is one of the techniques used for minimizing bleeding during FESS. [2] [3] [4] 34] Third, the amount of remifentanil infused during surgery was not compared between groups. We focused only on the effects of propofol and desflurane for controlled hypotension on the level of the biomarkers under conditions of routine anesthetic practice for controlled hypotension. Further, the biomarkers levels are compromised by extracranial injuries without brain injury. Hence, serial measuring and noting peripheral injury are important. [35] 
Conclusion
On comparing the effects of propofol/remifentanil and desflurane/remifentanil anesthesia for controlled hypotension on the levels of S-100b and GFAP during FESS, we noted that the levels of these biomarkers increased compared to base values, but there was no significant difference in S-100b and GFAP levels between the 2 study groups.
